CLL — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Chronic lymphocytic leukaemia
Lymphocytosis with mature lymphocytes, smear cells, and CD5+/CD19+/CD23+/weak sIg immunophenotype is diagnostic of CLL. Asymptomatic early-stage (Binet A/Rai 0) CLL is managed with watch-and-wait. Treatment is indicated for symptomatic disease or progressive cytopenias. First-line is now BTK inhibitors (ibrutinib, acalabrutinib) or venetoclax-obinutuzumab.
Reference: iwCLL – 2024 – CLL Guidelines; ALLG/HSANZ Australian CLL Recommendations